德西弗拉製藥公司
US ˙ NasdaqGS ˙ US24344T1016
該符號不再有效

SecurityDCPH / Deciphera Pharmaceuticals, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership175,148 shares
Latest Disclosed Value $ 3,240,238
Jefferies Group LLC ownership in DCPH / Deciphera Pharmaceuticals, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 175,148 shares of Deciphera Pharmaceuticals, Inc. (US:DCPH) valued at $3,240,238 USD as of September 30, 2022. The entity filed a previous 13F-HR/A on September 21, 2023 disclosing 691,000 shares of Deciphera Pharmaceuticals, Inc.. This represents a change in shares of -74.65% during the quarter. The current value of the position is $4,482,037 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (DCPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DCPH / Deciphera Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 175,148 -515,852 -74.65 3,240 -64.34 0.0271
2022-11-14 2022-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 188,518 -502,514 3,242 0.0258
2023-09-21 2022-06-30 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 691,000 -175,000 -20.21 9,087 13.19 0.0755
2022-08-15 2022-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 691,032 -174,968 9,087 0.0709
2023-09-21 2022-03-31 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 866,000 853,547 6,854.15 8,028 6,533.88 0.0505
2022-05-16 2022-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 867,334 854,881 8,029 0.0468
2023-09-21 2021-12-31 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 12,453 4,155 50.07 122 -56.94 0.0007
2022-02-14 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 12,453 4,155 122 0.0007
2023-09-21 2021-09-30 13F/A-2 DECIPHERA PHARMACEUTICALS IN COM 24344T101 8,298 -38,660 -82.33 282 -83.65 0.0021
2021-12-17 2021-09-30 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 8,298 -38,660 282 0.0019
2021-11-15 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 8,298 -38,660 282 0.0018
2023-09-21 2021-06-30 13F/A-2 DECIPHERA PHARMACEUTICALS IN COM 24344T101 46,958 29,131 163.41 1,719 115.14 0.0108
2021-08-20 2021-06-30 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 46,958 29,131 1,719 0.0102
2021-08-16 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 46,958 29,131 1,719 0.0102
2023-09-21 2021-03-31 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 17,827 17,827 799 0.0070
2021-05-14 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 17,827 17,827 799 0.0070
2023-09-21 2020-12-31 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 0 -6,550 -100.00 0 -100.00
2021-02-16 2020-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 0 -6,550 0
2020-11-13 2020-09-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 6,550 -10,554 -61.70 336 -67.09 0.0037
2020-11-02 2020-06-30 13F/A-1 DECIPHERA PHARMACEUTICALS IN COM 24344T101 17,104 5,689 49.84 1,021 117.23 0.0120
2020-08-14 2020-06-30 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 17,104 5,689 1,021 13,720.0497
2020-05-15 2020-03-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 11,415 -4,585 -28.66 470 -52.81 0.0058
2020-02-13 2019-12-31 13F DECIPHERA PHARMACEUTICALS IN COM 24344T101 16,000 16,000 996 0.0077
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-03-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 33,100 65.50 323 -52.43 n/a n/a n/a
2022-02-14 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 33,100 323 n/a n/a n/a
2021-12-17 2021-09-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 20,000 680 n/a n/a n/a
2023-09-21 2021-09-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 20,000 -67.74 680 -70.07 n/a n/a n/a
2021-11-15 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN COM Call 20,000 680 n/a n/a n/a
2021-08-20 2021-06-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 62,000 2,270 n/a n/a n/a
2023-09-21 2021-06-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 62,000 47.62 2,270 20.50 n/a n/a n/a
2021-08-16 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN COM Call 6,200,000 2,270 n/a n/a n/a
2023-09-21 2021-03-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 42,000 115.38 1,883 69.33 n/a n/a n/a
2021-05-14 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 42,000 1,883 n/a n/a n/a
2023-09-21 2020-12-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 19,500 0.00 1,113 11.20 n/a n/a n/a
2021-02-16 2020-12-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 19,500 1,113 n/a n/a n/a
2020-11-13 2020-09-30 13F DECIPHERA PHARMACEUTICALS IN COM Call 19,500 17.47 1,000 0.91 n/a n/a n/a
2020-11-02 2020-06-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Call 16,600 -66.73 991 -51.75 n/a n/a n/a
2020-08-14 2020-06-30 13F DECIPHERA PHARMACEUTICALS IN COM Call 16,600 991 n/a n/a n/a
2020-05-15 2020-03-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 49,900 66.33 2,054 10.02 n/a n/a n/a
2020-02-13 2019-12-31 13F DECIPHERA PHARMACEUTICALS IN COM Call 30,000 1,867 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-03-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F DECIPHERA PHARMACEUTICALS IN COM Put 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 10,900 0.00 106 -71.35 n/a n/a n/a
2022-02-14 2021-12-31 13F DECIPHERA PHARMACEUTICALS IN COM Put 10,900 106 n/a n/a n/a
2021-12-17 2021-09-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 10,900 370 n/a n/a n/a
2023-09-21 2021-09-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 10,900 -76.25 370 -77.98 n/a n/a n/a
2021-11-15 2021-09-30 13F DECIPHERA PHARMACEUTICALS IN COM Put 10,900 370 n/a n/a n/a
2021-08-20 2021-06-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 45,900 1,680 n/a n/a n/a
2023-09-21 2021-06-30 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 45,900 0.00 1,680 -18.37 n/a n/a n/a
2021-08-16 2021-06-30 13F DECIPHERA PHARMACEUTICALS IN COM Put 4,590,000 1,680 n/a n/a n/a
2023-09-21 2021-03-31 13F/A DECIPHERA PHARMACEUTICALS IN COM Put 45,900 2,058 n/a n/a n/a
2021-05-14 2021-03-31 13F DECIPHERA PHARMACEUTICALS IN COM Put 45,900 2,058 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.